Investor Relations

iCo was awarded a Gold Leaf Award as the Early Stage Company of the Year from BIOTECanada and is a Canada's Top 10™ Competition winner.  

iCo trades on the TSX Venture Exchange under the symbol "ICO".

Fact Sheets

Corporate Fact Sheet

iCo-007 Fact sheet

iCo-008 Fact sheet

Oral Amphotericin B Delivery System Fact sheet

News Releases

Jan 17, 2012:
iCo Therapeutics Retains Crescendo Communications
Dec 5, 2011:
iCo Therapeutics Announces Execution of Equity Line Facility Agreement
Nov 18, 2011:
iCo Therapeutics Announces Third Quarter 2011 Financial Results
Copyright 2010 ICO Therapeutics | Disclaimer